JUVEDERM Volbella XC
JUVÉDERM VOLBELLA XC is the latest addition to the JUVÉDERM collection of fillers, the number one selling collection of dermal filler products in the world to receive FDA approval. It is used for lip augmentation and for correction of perioral lines, in adults over the age of 21. In clinical trials, JUVÉDERM VOLBELLA XC was found to effectively increase lip fullness and soften the appearance of lines around the mouth in a majority of subjects through one year.
When seeking lip augmentation, patients want a smooth, result that is not drastic. JUVÉDERM VOLBELLA XC adds fullness to the lips and softens the appearance of the lines around the lips.
The safety and effectiveness of JUVÉDERM VOLBELLA XC has been demonstrated in several clinical trials including the U.S. pivotal study where 168 subjects were treated with JUVÉDERM VOLBELLA XC. A 5-point scale was used to evaluate the effectiveness of the product for lip fullness and a 4-point scale to evaluate the effectiveness of the product for smoothing lines around the mouth. Approximately two-thirds of subjects treated with VOLBELLA XC showed improvement in lip fullness and perioral lines through 1 year. The safety of JUVÉDERM VOLBELLA XC was observed to be similar to that of the control. The most common side effects were temporary responses at the treatment site such as swelling, tenderness, bruising, firmness lumps/bumps, redness, pain, discoloration, and itching. Most of these side effects resolved within 30 days.
JUVÉDERM VOLBELLA XC was first approved in Europe in 2011. Currently, JUVÉDERM VOLBELLA XC is distributed in more than 70 countries, including markets in Europe, Latin America, Middle East, Asia Pacific, and Canada. JUVÉDERM VOLBELLA XC is now available to patients in the United States as of October 2016. DermPartners is happy to offer this new and effective treatment to our patients.
21020 State Road 7
Boca Raton FL
Convenient office hours.
Appointments available from
7:00 AM Monday through Friday.
Evening hours are also available.